FDA Expediting Accelerated Development of Novel Therapies for COVID-19, page-7

  1. 473 Posts.
    lightbulb Created with Sketch. 800
    Reading this kinda make me sad. There they are a bunch of young scientists, some with no scientific background and yet they have so much influence on key decisions. Many of whom are investors, or otherwise can easily be influenced by conflict of interest, backing some of the biggest pharmas for fame or financial gain, while taking 0 risks if their recommendations failed; leading to loss of lives, delayed potential treatments that work and mis-direction of resources.

    Then look at MSB, successful Phase 3 aGVHD, two phase 3 results coming out soon, multiple successful Phase-2 including diabetes nephritis and IL-6 resistance RA. All of which have the same hall mark of OVER-INFLAMMATION. Yet MESO price dropped to level of or below prior to Covid-19. I mean I don't want MSB share price to be inflated, but at least reflect its actual potential of the treatment!!! We just produced the best result of any covid-19 treatments available on market didn't we? Anyway, I am preparing to accumulate
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.28
Change
-0.030(1.30%)
Mkt cap ! $2.918B
Open High Low Value Volume
$2.32 $2.39 $2.24 $13.10M 5.680M

Buyers (Bids)

No. Vol. Price($)
8 44474 $2.27
 

Sellers (Offers)

Price($) Vol. No.
$2.29 30176 3
View Market Depth
Last trade - 16.17pm 22/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.